Page-3 of COVAXIN
World Immunisation Week
The World Immunisation Week is celebrated every year in the last week of April. It aims to promote the use of vaccines. This year, in 2021, the World Immunisation Week is to be celebrated under the following theme: Theme: Vaccines ..
Month: Current Affairs - April, 2021
Infections after COVID Vaccination
The Indian Council of Medical Research recently reported that around two to four of the ten thousand vaccinated people tested positive for the disease. This is referred to as “Breakthrough Infection”. Key Findings of ICMR According to ICMR, around 9.3 ..
Month: Current Affairs - April, 2021
IndRa: Cost of vaccinating India’s population above 18 years 0.36% of GDP
The India Ratings and Research (Ind-Ra) recently said the estimated cost to vaccinate all the Indians of age 18 years will be Rs 67,193 crores. This is 0.36% of the GDP of the country. Key Findings The GoI recently announced ..
Month: Current Affairs - April, 2021
COVAXIN neutralises double Mutant Strain
The Indian Council of Medical Research recently announced that COVAXIN neutralises the Double Mutant Strain of COVID-19. Key Highlights The National Institute of Virology recently demonstrated the neutralisation potential of COVAXIN against the Brazil variant and UK variant. The B.1.617 ..
Month: Current Affairs - April, 2021
COVAXIN: Transfer of Technology from Bharat Biotech to Haffkine
The Government of India recently approved the transfer of technology from Bharat Biotech to Hafkine Institute. COVAXIN COVAXIN is one of the two drugs that is currently administered in India. It is manufactured by Bharat Biotech in collaboration with the ..
Month: Current Affairs - April, 2021
Why is GoI fast tracking the Emergency use of foreign made COVID-19 Vaccines?
The Government of India recently announced that it is speeding up the Emergency Usage Approvals of foreign made COVID-19 vaccines. This includes COVID-19 vaccines that have been granted Emergency Use Authorisation (EUA) in other countries. Role of NEGVAC in the ..